in COVID-19 patients with mild to moderate symptoms [59].

2.4. Clevudine (Levovir and Revovir)
It a thymidine nucleoside analog (Figure 3) that was approved in Korea for the treatment of hepatitis B virus (HBV) infection [60]. Similar to previous agents, it